Clinical Trials Logo

Sedation Complication clinical trials

View clinical trials related to Sedation Complication.

Filter by:

NCT ID: NCT05567718 Completed - Delirium Clinical Trials

The Relationship Between Fasting Time and Delirium

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

We investigated the relationship between fasting times and delirium in children undergoing MRI under anesthesia. Paediatric Anaesthesia Emergence Delirium (PAED) scale, last oral intake time and type of food (solid-liquid) and fasting time, laryngospasm, desaturation (SpO2 <95%), bradycardia, allergy, nausea and vomiting were recorded.

NCT ID: NCT05505279 Recruiting - Hypercapnia Clinical Trials

Ventilatory Effects of THRIVE During EBUS

Start date: October 5, 2022
Phase: Phase 3
Study type: Interventional

High flow nasal cannula (HFNC) is used in interventional procedures to prevent hypoxia during sedation. In patients with a patent airway, HFNC reduces dead space ventilation as well. It is unknown if dead space ventilation is also reduced by HFNC in an EndoBroncheal UltraSound procedure, in which the airway is partially blocked by the endoscope. Especially in patients with Chronic Obstructive Pulmonary Disease (COPD) the partial blocking of the airway may reduce ventilation. If HFNC is able to reduce dead space during an EBUS-procedure, it may facilitate CO2 clearance, which may lead to a reduction in work of breathing. This study aims to investigate if HFNC reduces dead space ventilation in patients undergoing an EBUS-procedure and if this is flow-dependent. A randomized, double-blinded, cross-over study is designed.

NCT ID: NCT05451381 Completed - Clinical trials for Hemodynamic Instability

Vasopressor Requirements Depends on Sedation Strategy

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Most of the patients after cardiac surgery need sedation in the iCU. Sedation strategy could impact the incidence of vasopressor use.

NCT ID: NCT05451121 Completed - Respiratory Failure Clinical Trials

Effect of Sedation Strategy on Duration Mechanical Ventilation in Patient After Cardiac Surgery

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

There is a direct relationship between the sedative agent and the duration of ventilation.

NCT ID: NCT05437497 Recruiting - Clinical trials for Sedation Complication

Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

This study aims to compare the safety and efficacy of remimazolam and propofol in EUS-FNA/FNB sedation. This study is a prospective, single-blind study. We plan to enroll 264 patients undergoing EUS-FNA and divide them into two groups. The experimental group was sedated with remimazolam, and the control group was sedated with propofol; safety and efficacy parameters such as intraoperative blood pressure, finger pulse oxygen, heart rate and sedation success rate would be compared. We hypothesized that patients in the experimental group would be superior in terms of safety parameters; the two would be equal in terms of sedation success.

NCT ID: NCT05423821 Not yet recruiting - Clinical trials for Sedation Complication

Non-operating Room Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases

Start date: June 14, 2022
Phase:
Study type: Observational

In recent years, out patient anesthesia applications have been increasing for diagnostic and interventional procedures for pediatric patients. In this study, we aimed to retrospectively analyze the anesthesia applications performed in pediatric MRI cases in our hospital. It is a retrospective study

NCT ID: NCT05407870 Recruiting - Clinical trials for Sedation Complication

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

Start date: June 9, 2022
Phase: N/A
Study type: Interventional

During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effects are frequently observed. However, etomidate is known to have hemodynamic and respiratory stability.The purpose of this study was to compare the efficacy and safety of etomidate and propofol in sedated gastric endoscopic submucosal dissection.

NCT ID: NCT05399758 Suspended - Nociceptive Pain Clinical Trials

Nociception Evaluated by the NOL® Index in Sedated Patients in the Intensive Care Unit

Start date: June 1, 2022
Phase:
Study type: Observational

Due to their underlying pathology and the necessary complicated procedures to which they are exposed, patients in the intensive care unit experience varying degrees of pain at some point in their evolution. Evidence has established short-term and long-term negative consequences of unresolved pain or excessive analgesic sedation. However, pain assessment or adequate nociceptive monitoring remains a significant challenge, especially in non-communicative patients under deep sedation, who urgently need to expand and improve current tools. Pain assessment in critically ill patients is challenging; limitations in their ability to communicate (neurocognitive deficit, use of endotracheal tube) or altered consciousness (deep sedation) make them unable to self-report their pain with standard pain scales. The Behavioral Pain Scale (BPS) and the Critical-Care Pain Observation Tool (CPOT) are the pain assessment tools with the best performance and reliability for patients in these conditions. Different technologies are used to monitor nociceptive responses caused by surgical stress in patients under general anesthesia that together with the clinical evaluation, manage to keep patients in the best analgesic conditions, improving the post-surgical prognosis. In particular, the NOL® nociceptive index (Medasense, Ramat Gan, Israel) is a multiparametric detection of nociception/pain, delivering a dimensionless score (0 -100) calculated through an algorithm (patented) and based on the registry of four biometric sensors (photoplethysmography, galvanic skin response, temperature, and accelerometer). NOL index value between 10-25 is the most appropriate for maintaining analgesia during general anesthesia. The ease and low invasiveness of this system (all sensors are implemented in a finger clip, similar to an oxygen saturation monitor) may allow its potential use in the context of intensive care unit patients. Some studies have recently been published that highlight the possible usefulness of the NOL® index in critically ill patients. However, in these studies, the assessment of nociception was limited to acute nociceptive procedures only.

NCT ID: NCT05371886 Recruiting - Clinical trials for Sedation Complication

Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This study aims to describe a dose-effect relationship of morphine alone and morphine and midazolam administered as continuous infusion in neonates hospitalized in Neonatal intensive care unit and undergoing mechanical ventilation, through PKPD modelling.

NCT ID: NCT05350085 Recruiting - Dental Anxiety Clinical Trials

Remimazolam in the Extraction of Impacted Wisdom Teeth

Start date: April 18, 2022
Phase: N/A
Study type: Interventional

Benzodiazepines, represented by midazolam, are often used for sedation in outpatient surgery in dentistry. However, midazolam has the problems of slow consciousness recovery and long recovery time, which brings trouble to the patients. Remimazolam is a new type of ultra short acting sedative anesthetic. Compared with other similar products, remimazolam has faster effect, rapid metabolism and has no accumulation, which may mean that compared with midazolam, remimazolam has a better clinical application prospect in dental outpatient surgery.